Valeant Will Pay Anacor $143M Over Anti-Fungal Dispute
Valeant Pharmaceuticals International Inc. said Monday it will pay $142.5 million to Anacor Pharmaceuticals Inc. to settle a contract dispute concerning Valeant's developmental nail fungus treatment....To view the full article, register now.
Already a subscriber? Click here to view full article